Skip to main content

Advertisement

SpringerLink
Log in

P-Glycoprotein Expression in Indian Breast Cancer Patients with Reference to Molecular Subtypes and Response to Anthracycline-Based Chemotherapy—a Prospective Clinical Study from a Developing Country

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Chemo-resistance is an important factor determining the response of tumor to neoadjuvant chemotherapy (NACT). Our study was aimed to determine the role of P-glycoprotein (P-glyp) expression as a predictor of response to NACT in locally advanced breast cancer (LABC) patients with special reference to molecular subtypes. Sixty cases of locally advanced breast cancer (LABC) were subjected to trucut biopsy and the tissue samples were evaluated immunohistochemically for P-glyp, ER, PR, and Her 2 neu status. Pre- and post-NACT P-glyp expression was correlated with clinical response (using WHO criteria after three cycles of CEF regimen) and molecular subtypes. The change in the P-glyp expression before (pre-) and after (post-) NACT was statistically significant with higher stage (p = 0.02), hormonal negative molecular subtypes (p = 0.01), and poor clinical response (p = 0.01). Pre-NACT-positive P-glyp expression is associated with higher stage and hormonal negative molecular subtypes and poor clinical response. The increased expression of P-glyp induced by NACT likely explains the concept of acquired chemo-resistance and may prove as an intermediate checkpoint in determining chemo-sensitivity for further treatment so that additional doses of ineffective chemotherapy may be avoided in non-responders translating into better patient safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. International Agency for Research on Cancer, Lyon

    Google Scholar 

  2. Deo SV, Bhutani M, Shukla NK, Raina V, Rath GK, Purkayasth J (2003) Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). J Surg Oncol 84:192–197

    Article  CAS  Google Scholar 

  3. Charfare H, Limongelli S, Purushotham AD (2005) Neoadjuvant chemotherapy in breast cancer. Br J Surg 92:14–23

    Article  CAS  Google Scholar 

  4. Heys SD, Chaturvedi S (2003) Primary chemotherapy in breast cancer: the beginning of the end or end of the beginning for the surgical oncologist? World J Surg Oncol 1(1):14

    Article  Google Scholar 

  5. Chintamani, Singhal V, Singh JP, Lyall A, Saxena S, Bansal A (2004) Is drug induced toxicity a good predictor of response to neoadjuvant chemotherapy in patients with breast cancer? – a prospective clinical study. BMC Cancer 4:48

    Article  CAS  Google Scholar 

  6. Smith IE, Detre S, Burton SA, Salter J, A'Hern R, Walsh G et al (1998) Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy. Breast Cancer Res Treat 48:107–116

    Article  Google Scholar 

  7. Nielsen DL (2004) Mechanisms and functional aspects of multidrug resistance in Ehrlich ascites tumor cells. Dan Med Bull 51:393–414

    CAS  PubMed  Google Scholar 

  8. Fung KL, Gottesman MM (2009) A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta 1794:860–871

    Article  CAS  Google Scholar 

  9. Kerr JF, Winterford CM, Hormon BV (1994) Apoptosis: its significance in cancer and cancer therapy. Cancer 73:2013–2026

    Article  CAS  Google Scholar 

  10. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, Mc Neese MD, Paulus D et al (1988) Management of stage lIl primary breast cancer with primary chemotherapy, surgery and radiotherapy. Cancer 62:2507–2516

    Article  CAS  Google Scholar 

  11. McCready DR, Hortobagyi GN, Kau SW, Smith TL, Buzdar AU, Balch CM (1989) The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 124:21–25

    Article  CAS  Google Scholar 

  12. Gerlach JH, Kartner N, Bell DR, Ling V (1986) Multidrug resistance. Cancer Surv 5:25–46

    CAS  PubMed  Google Scholar 

  13. Wishart GC, Plumb JA, Going JJ, McNicol AM, McArdle CS, Tsuruo T et al (1990) P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer 62:758–761

    Article  CAS  Google Scholar 

  14. Schneider J, Bak M, Efferth T, Kaufmann M, Mattern J, Volm M (1989) Pglycoprotein expression in treated and untreated human breast cancer. Br J Cancer 60:815–818

    Article  CAS  Google Scholar 

  15. Chan HS, Bradley G, Thorner P, Haddad G, Gallie BL, Ling V (1988) A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines. Lab Investig 59:870–875

    CAS  PubMed  Google Scholar 

  16. Merkel DE, Fuqua SA, Tandon AK, Hill SM, Buzdar AU, McGuire WL (1989) Electrophoretic analysis of 248 clinical breast cancer specimens for p-glycoprotein overexpression or gene amplification. J Clin Oncol 7:1129–1136

    Article  CAS  Google Scholar 

  17. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BG, Taylor CW et al (1989) Drug resistance in multiple myeloma and non-Hodgkin’s lymphoma; detection of p-glycoprotein circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7:415–424

    Article  CAS  Google Scholar 

  18. Chan HS, Thorner PS, Haddad G, Ling V (1990) Immunohistochemical detection of p-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8:689–704

    Article  CAS  Google Scholar 

  19. Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S et al (1988) Tissue distribution of p-glycoprotein encoded by a multidrug resistant gene as revealed by a monoclonal antibody, MRK16. Cancer Res 48:1926–1929

    CAS  PubMed  Google Scholar 

  20. Koh EH, Chung HC, Lee KB, Lim HY, Kim JH, Roh JK et al (1992) The value of immunohistochemical detection of pglycoprotein in breast cancer before and after induction chemotherapy. Yonsei Med J 33:137–142

    Article  CAS  Google Scholar 

  21. Chung HC, Rha SY, Kim JH, Roh JK, Min JS, Lee KS et al (1997) P-glycoprotein: the immediate end point of drug resistance to induction chemotherapy in locally advanced breast cancer. Breast Cancer Res Treat 42:65–72

    Article  CAS  Google Scholar 

  22. Ro J, Shin A, Ro JY, Fritsche H, Hortobagyi G, Blick M (1990) Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol 21:787–791

    Article  CAS  Google Scholar 

  23. Verrelle P, Meissonnier F, Fonck Y, Feillel V, Dionet C, Kwiatkowski F et al (1991) Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 83:111–116

    Article  CAS  Google Scholar 

  24. Eltahir A, Heys SD, Hutcheon AW, Sarkar TK, Smith I, Walker LG et al (1998) Treatment of large and locally advanced breast cancer using neoadjuvant chemotherapy. Am J Surg 175:127–132

    Article  CAS  Google Scholar 

  25. Bonadonna G, Valagussa P, Moliterni ZM, Brambilla C (1995) Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 332:901–906

    Article  CAS  Google Scholar 

  26. Vishnukumar S, Umamaheswaran G, Anichavezhi D, Indumathy S, Adithan C, Srinivasan K et al (2013) P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer. Indian J Cancer 50:195–199

    Article  CAS  Google Scholar 

  27. Tashbaeva RE, Hwang DN, Song GS, Choi NH, Lee JH, Lyoo YS et al (2007) Cellular characterization of multidrug resistance P-glycoprotein, alpha fetoprotein, and neovascular endothelium-associated antigens in canine hepatocellular carcinoma and cirrhotic liver. Vet Pathol 44:600–606

    Article  CAS  Google Scholar 

  28. Singh G, Singh DP, Gupta D, Muralikrishna BV (1996) Neoadjuvant chemotherapy in locally advanced breast cancer. J Surg Oncol 61:38–41

    Article  CAS  Google Scholar 

  29. Morrow M, Braverman A, Thelmo W, Sohn CK, Sand J, Mora M et al (1986) Multimodal therapy for locally advanced breast cancer. Arch Surg 121:1291–1296

    Article  CAS  Google Scholar 

  30. Linn SC, Giaccone G, Van Diest PJ, Blokhuis WM, van der Valk P, van Kalken CK et al (1995) Prognostic relevance of p-glycoprotein expression in breast cancer. Ann Oncol 6:679–685

    Article  CAS  Google Scholar 

  31. Trock BJ, Leonassa F, Clarke R (1997) Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J Natl Cancer Inst 89:917–931

    Article  CAS  Google Scholar 

  32. De Lena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G (1978) Combination chemotherapy, radiotherapy approach in locally advanced breast cancer. Cancer Chemother Pharmacol 1:53–59

    Article  Google Scholar 

  33. Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z (1995) Pathological response to induction chemotherapy in locally advanced carcinoma of breast, a determinant of out come. J Am Coll Surg 180:297–306

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, King George’s Medical University, Lucknow, UP, India

    Mudit Mehrotra, Akshay Anand & Surender Kumar

  2. Department of Endocrine Surgery, King George’s Medical University, Lucknow, UP, India

    Kul Ranjan Singh

  3. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, UP, India

    Nuzhat Husain

  4. King George’s Medical University, Lucknow, UP, India

    Abhinav Arun Sonkar

Authors
  1. Mudit Mehrotra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akshay Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kul Ranjan Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Surender Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nuzhat Husain
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abhinav Arun Sonkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MM contributed in the literature search, data acquisition, data analysis, and manuscript preparation and manuscript editing.

AA contributed in literature search, design, definition of intellectual content, data analysis, statistical analysis and manuscript preparation and editing.

KRS contributed in design, definition of intellectual content, data analysis, statistical analysis and manuscript preparation and editing.

SK contributed in literature search, data acquisition and manuscript preparation.

NH contributed in the data analysis, manuscript editing and review.

AAS contributed in the concept, design, and definition of intellectual content, manuscript editing and review.

Corresponding author

Correspondence to Abhinav Arun Sonkar.

Ethics declarations

Conflicts of Interest

The authors declare that they have no conflict of interest.

Additional information

All authors have read the manuscript and approve it in its current form. The requirements for authorship as stated earlier in this document have been met, and that each one of us believes that the manuscript represents honest work and is not being elsewhere for consideration.

Department of Surgery, King George’s Medical University, Lucknow, India, in collaboration with the Department of Pathology, RML Institute of Medical Sciences, Lucknow, India.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mehrotra, M., Anand, A., Singh, K.R. et al. P-Glycoprotein Expression in Indian Breast Cancer Patients with Reference to Molecular Subtypes and Response to Anthracycline-Based Chemotherapy—a Prospective Clinical Study from a Developing Country. Indian J Surg Oncol 9, 524–529 (2018). https://doi.org/10.1007/s13193-018-0797-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-018-0797-8

Keywords

Search

Navigation